Diabetes mellitus in patients receiving hypertransfusion for thalassemia major is usually attributed to damage to beta cells. To determine whether iron overload leads to insulin resistance before the development of insulin deficiency, insulin was infused (by euglycemic insulin-clamp technique) into 12 children with thalassemia (4 of whom were prepubertal, and 8 pubertal) who had normal or only moderately impaired glucose tolerance and who were receiving chelation therapy. Although insulin-stimulated glucose metabolism in the prepubertal children with thalassemia was similar to that in controls (normal prepubertal children) (319 +/- 23 vs. 314 +/- 41 mg per square meter of body-surface area per minute, P not significant), the response to insulin was markedly impaired in the pubertal children with thalassemia (155 +/- 18 vs. 224 +/- 15 mg per square meter per minute in normal pubertal controls, P less than 0.01). Plasma insulin levels rose excessively after oral glucose administration in the pubertal subjects with thalassemia, but not in the prepubertal patients (P less than 0.001). Furthermore, in response to a standard hyperglycemic stimulus, insulin levels in the pubertal patients rose to two to three times greater than normal and C-peptide levels became significantly elevated. Our data suggest that insulin resistance and increased insulin secretion develop in older children with thalassemia treated with long-term hypertransfusion therapy before the development of diabetes.
Source Information
Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06510.
This article has been cited by other articles:
Raskauskas, T. A., Fisken, R. A., Targher, G., Lippi, G., Moghetti, P., Mascitelli, L., Pezzetta, F., Goldstein, M. R., Nestler, J. E.
(2008). Metformin in Polycystic Ovary Syndrome. NEJM
358: 1866-1868
[Full Text]
Mascitelli, L., Pezzetta, F.
(2008). Does metformin improve polycystic ovary syndrome symptoms through reduction in body iron stores?. Eur J Endocrinol
158: 439-439
[Full Text]
Equitani, F., Fernandez-Real, J. M., Menichella, G., Koch, M., Calvani, M., Nobili, V., Mingrone, G., Manco, M.
(2008). Bloodletting Ameliorates Insulin Sensitivity and Secretion in Parallel to Reducing Liver Iron in Carriers of HFE Gene Mutations. Diabetes Care
31: 3-8
[Abstract][Full Text]
Luque-Ramirez, M., Alvarez-Blasco, F., Botella-Carretero, J. I., Sanchon, R., San Millan, J. L., Escobar-Morreale, H. F.
(2007). Increased Body Iron Stores of Obese Women With Polycystic Ovary Syndrome Are a Consequence of Insulin Resistance and Hyperinsulinism and Are Not a Result of Reduced Menstrual Losses. Diabetes Care
30: 2309-2313
[Abstract][Full Text]
Swaminathan, S., Fonseca, V. A., Alam, M. G., Shah, S. V.
(2007). The Role of Iron in Diabetes and Its Complications. Diabetes Care
30: 1926-1933
[Full Text]
Porter, J R, Barrett, T G
(2004). Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management. Arch. Dis. Child.
89: 1138-1144
[Abstract][Full Text]
Joshi, D.-D., Nickerson, H. J., McManus, M. J.
(2004). Hydrops Fetalis Caused by Homozygous {alpha}-Thalassemia and Rh Antigen Alloimmunization: Report of a Survivor and Literature Review. Clin Med Res
2: 228-232
[Abstract][Full Text]
Jiang, R., Manson, J. E., Meigs, J. B., Ma, J., Rifai, N., Hu, F. B.
(2004). Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy Women. JAMA
291: 711-717
[Abstract][Full Text]
Tong, P. C.Y., Ng, M. C.Y., Ho, C. S., So, W. Y., Li, J. K.Y., Lam, C. W.K., Cockram, C. S., Chan, J. C.N.
(2002). C-Reactive Protein and Insulin Resistance in Subjects With Thalassemia Minor and a Family History of Diabetes. Diabetes Care
25: 1480-1481
[Full Text]
Fernandez-Real, J. M., Lopez-Bermejo, A., Ricart, W.
(2002). Cross-Talk Between Iron Metabolism and Diabetes. Diabetes
51: 2348-2354
[Abstract][Full Text]
Fernandez-Real, J. M., Penarroja, G., Castro, A., Garcia-Bragado, F., Hernandez-Aguado, I., Ricart, W.
(2002). Blood Letting in High-Ferritin Type 2 Diabetes : Effects on Insulin Sensitivity and {beta}-Cell Function. Diabetes
51: 1000-1004
[Abstract][Full Text]
Moczulski, D. K., Grzeszczak, W., Gawlik, B.
(2001). Role of Hemochromatosis C282Y and H63D Mutations in HFE Gene in Development of Type 2 Diabetes and Diabetic Nephropathy. Diabetes Care
24: 1187-1191
[Abstract][Full Text]
Chern, J. P.S., Lin, K.-H., Lu, M.-Y., Lin, D.-T., Lin, K.-S., Chen, J.-D., Fu, C.-C.
(2001). Abnormal Glucose Tolerance in Transfusion-Dependent {beta}-Thalassemic Patients. Diabetes Care
24: 850-854
[Abstract][Full Text]
Sparacia, G., Iaia, A., Banco, A., D'Angelo, P., Lagalla, R.
(2000). Transfusional Hemochromatosis: Quantitative Relation of MR Imaging Pituitary Signal Intensity Reduction to Hypogonadotropic Hypogonadism. Radiology
215: 818-823
[Abstract][Full Text]
Fields, M.
(1998). Nutritional Factors Adversely Influencing the Glucose/Insulin System. J. Am. Coll. Nutr.
17: 317-321
[Abstract][Full Text]
Olivieri, N. F., Brittenham, G. M.
(1997). Iron-Chelating Therapy and the Treatment of Thalassemia. Blood
89: 739-761
[Full Text]
Previous
